The Ensign Group, Inc. (ENSG) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

The Ensign Group, Inc. (ENSG) Healthcare & Pipeline Overview

The Ensign Group, Inc. delivers skilled nursing and rehabilitative care services, operating 252 healthcare facilities across 13 states. Specializing in post-acute care, Ensign offers a continuum of services including short-term rehabilitation, long-term care, and ancillary services, positioning itself as a key player in the growing healthcare services market.

What Is the Investment Thesis for ENSG?

The Ensign Group, Inc. presents a compelling investment case driven by its strategic positioning in the growing post-acute care market. With a market capitalization of $10.5B and a P/E ratio of 25.5, the company showcases solid financial metrics. A key value driver is the increasing demand for skilled nursing and rehabilitative services, fueled by an aging population and rising chronic disease prevalence. Growth catalysts include ongoing expansion through acquisitions and organic growth initiatives, leveraging their established operational model. The company's focus on ancillary services further diversifies revenue streams. However, potential risks include regulatory changes and reimbursement pressures within the healthcare industry. The company's beta of 0.82 suggests lower volatility compared to the broader market.

Based on FMP financials and quantitative analysis

ENSG Key Highlights

Market Cap of $10.5B reflects substantial investor confidence in Ensign's market position.

• P/E Ratio of 25.5 indicates a premium valuation, suggesting expectations of future earnings growth.
• Profit Margin of 6.9% demonstrates the company's ability to generate profits from its operations.
• Gross Margin of 13.9% highlights the efficiency of Ensign's service delivery and cost management.
• Dividend Yield of 0.15% provides a modest income component for investors.

Who Are ENSG's Competitors?

ENSG is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ENSG's Key Strengths?

Established presence in multiple states.

• Proven acquisition and integration strategy.
• Diversified service offerings.
• Experienced management team.

What Are ENSG's Weaknesses?

Exposure to regulatory and reimbursement risks.

• Dependence on government funding (Medicare/Medicaid).
• Potential for labor shortages in the healthcare industry.
• Relatively low dividend yield compared to peers.

What Could Drive ENSG Stock Higher?

Continued acquisitions of underperforming facilities, driving revenue growth and profitability.

• Expansion of ancillary services, such as mobile diagnostics, creating new revenue streams.
• Potential changes in government regulations that could benefit skilled nursing facilities.
• Increasing demand for post-acute care services due to the aging population.

What Are the Key Risks for ENSG?

Insider selling — insiders were net sellers of roughly $1.3M recently.

• Changes in government regulations and reimbursement policies could negatively impact revenue.
• Increased competition from other healthcare providers could put pressure on pricing and margins.
• Rising labor costs could impact profitability.
• Lawsuits and liability claims could result in significant financial losses.
• Economic downturn could reduce demand for elective healthcare services.

What Are the Growth Opportunities for ENSG?

• Expansion through Acquisitions: The Ensign Group has a proven track record of acquiring and integrating healthcare facilities. The market for skilled nursing facilities remains fragmented, presenting ongoing opportunities for strategic acquisitions. By acquiring underperforming facilities and implementing its operational model, Ensign can drive revenue growth and improve profitability. This strategy allows for geographic expansion and increased market share in key regions. The total addressable market for skilled nursing facilities is estimated at $180 billion annually.
• Organic Growth Initiatives: In addition to acquisitions, Ensign focuses on organic growth by enhancing the quality of care and expanding services within its existing facilities. This includes investing in new technologies, improving staff training, and developing specialized programs for specific patient populations. By enhancing its service offerings, Ensign can attract more patients and increase revenue per facility. The company is targeting a 5-7% annual organic growth rate.
• Development of Ancillary Services: Ensign is expanding its ancillary services, such as mobile diagnostics and therapy services, to generate additional revenue streams and enhance its competitive position. These services provide convenience and value to patients and healthcare providers, creating opportunities for cross-selling and increased customer loyalty. The market for mobile diagnostics is projected to reach $40 billion by 2028, representing a significant growth opportunity for Ensign.
• Senior Living Expansion: Ensign's senior living segment presents another avenue for growth. As the senior population continues to grow, the demand for senior living facilities is expected to increase. By expanding its senior living offerings, Ensign can cater to a broader range of patient needs and generate additional revenue. The senior living market is projected to reach $150 billion by 2027.
• Real Estate Leasing: The Real Estate segment provides a stable source of revenue through leasing properties to healthcare facilities. By strategically managing its real estate portfolio, Ensign can generate consistent rental income and capitalize on the increasing demand for healthcare facilities. The company can also develop new facilities to meet the growing needs of the healthcare market. The commercial real estate market for healthcare facilities is expected to grow at a rate of 4-5% annually.

What Are ENSG's Competitive Advantages?

• Established network of 252 healthcare facilities across 13 states.
• Proven operational model for improving the performance of acquired facilities.
• Diversified service offerings across the post-acute care continuum.
• Strong relationships with hospitals and healthcare providers.

What Does ENSG Do?

The Ensign Group, Inc., founded in 1999 and headquartered in San Juan Capistrano, California, is a leading provider of healthcare services within the post-acute care continuum. The company operates through two primary segments: Skilled Services and Real Estate. The Skilled Services segment offers a comprehensive range of services, including short and long-term nursing care for individuals with chronic conditions, prolonged illnesses, and elderly patients. This segment also provides physical, occupational, and speech therapies, along with other rehabilitative and healthcare services. In addition to these specialized services, Ensign provides standard offerings such as room and board, tailored nutritional programs, social activities, recreational events, and entertainment. The Real Estate segment focuses on leasing real estate properties, supporting the operational infrastructure of the healthcare facilities. Ensign also delivers senior living options and mobile diagnostic services, extending its reach to patients in various settings, including their homes and long-term care facilities. These ancillary services encompass digital x-ray, ultrasound, electrocardiogram, laboratory testing, sub-acute care, and patient transportation. As of April 4, 2022, The Ensign Group operated 252 healthcare facilities across Arizona, California, Colorado, Idaho, Iowa, Kansas, Nebraska, Nevada, South Carolina, Texas, Utah, Washington, and Wisconsin, demonstrating a significant geographic footprint in the healthcare sector.

What Products and Services Does ENSG Offer?

• Provide short-term rehabilitation services.
• Offer long-term nursing care for chronic conditions.
• Deliver physical, occupational, and speech therapies.
• Provide standard services like room and board and nutritional programs.
• Offer senior living options.
• Provide mobile diagnostic services (x-ray, ultrasound, EKG).
• Lease real estate properties to healthcare operators.

How Does ENSG Make Money?

• Generate revenue through skilled nursing and rehabilitative care services.
• Earn income from real estate leasing to healthcare facilities.
• Provide ancillary services such as mobile diagnostics and patient transportation.
• Focus on acquiring and improving underperforming healthcare facilities.

What Industry Does ENSG Operate In?

The Ensign Group operates within the medical care facilities industry, which is experiencing growth due to the aging population and increasing demand for post-acute care services. The industry is characterized by a mix of large national chains and smaller regional players. Key trends include a shift towards value-based care, increasing use of technology to improve patient outcomes, and growing regulatory scrutiny. Ensign competes with companies like Encompass Health Corporation (EHC) and other regional providers. The industry is expected to continue growing, driven by demographic trends and advancements in medical technology.

Who Are ENSG's Key Customers?

• Patients requiring short-term rehabilitation after surgery or illness.
• Elderly individuals needing long-term nursing care.
• Hospitals and healthcare providers seeking post-acute care services for their patients.
• Senior citizens seeking independent or assisted living options.

The Ensign Group, Inc. (ENSG) Valuation Context

Valued at $10.5B, ENSG is classified as a large-cap stock. Relative to its peer group, ENSG's quantitative score of 75/100 is roughly in line with the peer average of 72/100.

ENSG Revenue & Earnings Trend

In Q2 2026, ENSG generated $1.44B in top-line revenue, marking a sequential increase of 3.7%. The company recorded net income of $99.7M, with diluted EPS of $1.68. Revenue has increased across the last three reported quarters, suggesting sustained momentum for this large-cap Healthcare company. Across the four most recent quarters, ENSG averaged $1.59 in diluted EPS.

Company Profile

The Ensign Group, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in San Juan Capistrano, US. The company is led by CEO Barry R. Port. ENSG has traded publicly since 2007.

Return on equity for The Ensign Group, Inc. stands at 16.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 6.5%, showing how much profit it generates from its asset base. ENSG trades at a trailing price-to-earnings ratio of 25.49, above the Healthcare sector average of ~23x. Its free cash flow yield is 4.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.56 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.9%, the inverse of the P/E and a quick read on earnings relative to price.

The Ensign Group, Inc.'s Piotroski F-Score is 7/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 3.69 places it in the safe zone, indicating low near-term bankruptcy risk.

The Ensign Group, Inc. has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 2.8% above estimates on average.

Wall Street analysts project The Ensign Group, Inc. revenue of about $5.90B for fiscal 2026, with EPS near $7.79. The estimate reflects 4 contributing analysts.

Over the past six months, The Ensign Group, Inc. insiders filed 30 SEC Form 4 transactions — 22 sales and 8 purchases. On net that is roughly 3K shares disposed (about $1.3M), a signal worth weighing alongside the fundamentals.

ENSG Financials

ENSG Latest News

ENSG Analyst Consensus

ENSG MoonshotScore

Latest The Ensign Group, Inc. Analysis

The Ensign Group, Inc. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources